Docusign, Inc.: Form 10-Q for the period ended Jul 31, 2021
Filed with the SEC on Sep 3, 2021 and accepted by EDGAR at Sep 3, 2021, 16:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-05-01 to 2021-07-31 | $511.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2021-02-01 to 2021-07-31 | $980.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-05-01 to 2021-07-31 | $113.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2021-02-01 to 2021-07-31 | $219.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-05-01 to 2021-07-31 | $398.1m | us-gaap:GrossProfit |
| Gross profit | 6 months2021-02-01 to 2021-07-31 | $761.9m | us-gaap:GrossProfit |
| Research and development | 3 months2021-05-01 to 2021-07-31 | $94.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-02-01 to 2021-07-31 | $180.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-05-01 to 2021-07-31 | −$22.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-02-01 to 2021-07-31 | −$33.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-05-01 to 2021-07-31 | $1.7m | us-gaap:InterestExpense |
| Interest expense | 6 months2021-02-01 to 2021-07-31 | $3.3m | us-gaap:InterestExpense |
| Income tax | 3 months2021-05-01 to 2021-07-31 | $158.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-02-01 to 2021-07-31 | $2.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-05-01 to 2021-07-31 | −$25.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-02-01 to 2021-07-31 | −$33.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-05-01 to 2021-07-31 | −$0.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-02-01 to 2021-07-31 | −$0.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-05-01 to 2021-07-31 | −$0.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-02-01 to 2021-07-31 | −$0.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-05-01 to 2021-07-31 | 195,996,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-02-01 to 2021-07-31 | 195,183,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-02-01 to 2021-07-31 | $313.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-02-01 to 2021-07-31 | $28.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-07-31 | $518.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-07-31 | $1.18bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-07-31 | $2.36bn | us-gaap:Assets |
| Current liabilities | At period end2021-07-31 | $1.21bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-07-31 | $2.14bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2021-07-31 | $18.6m | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2021-07-31 | $211.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001261333-21-000163. Last ingested by Listed: Nov 5, 2026, 13:21 ET. Listed shows no prices and gives no investment advice.